On 1 August 2000, the Kennedy Institute of Rheumatology merged with Imperial College, becoming the ninth division of the Imperial College School of Medicine.
 |
| Image-7 |
Its primary focus was on basic and clinical research into the aetiology of rheumatoid and osteoarthritis and to develop preventative and therapeutic interventions.
Research at the Kennedy Institute resulted in the development of anti-TNF therapy for the treatment of rheumatoid arthritis by Professors RavinderMaini and Marc Feldmann, for which they were awarded the 2000 Crafoord Prize by the Royal Swedish Academy of Sciences and the 2003 Lasker Award, known as America's Nobel.
No comments:
Post a Comment